Detalhe da pesquisa
1.
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
N Engl J Med
; 389(9): 820-832, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646679
2.
Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.
Malar J
; 12: 312, 2013 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24010572
3.
Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea.
Aliment Pharmacol Ther
; 52(5): 808-820, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702169
4.
Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.
Clin Pharmacol Drug Dev
; 5(1): 76-82, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119581
5.
Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
J Clin Pharmacol
; 51(6): 933-42, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20852001